Journal
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
Volume 12, Issue 6, Pages 621-630Publisher
AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajgp.12.6.621
Keywords
-
Categories
Funding
- NIA NIH HHS [R01 AG17524] Funding Source: Medline
- NIMH NIH HHS [K07-MH01350] Funding Source: Medline
Ask authors/readers for more resources
Objective: Authors investigated the association between estrogen replacement therapy (ERT) and dopamine transporter (DAT) availability in women. Methods: Thirteen postmenopausal women were administered ERT and underwent neuroimaging, using single-photon emission computed tomography (SPECT) and [Tc-99m]TRODAT-1, a radioligand that binds DAT In this 64eek pilot study, subjects underwent SPECT before ERT, after 4 weeks of 0.625 mg/day of conjugated estrogens (CEE), and after an additional 2 weeks of 0.625 mg/day CEE plus 10 mg/day of medroxyprogesterone acetate. Specific uptake values (SUVs) of [Tc-99m]TRODAT-1 were calculated for the caudate and putamen. Results: When compared with baseline values, [Tc-99m]TRODAT-1 binding demonstrated a modest, but statistically significant, increase in the left anterior putamen after 4 weeks of CEE. After the 64eek ERT intervention, both the left and right anterior putamen demonstrated an increase in SUVs. Conclusion: Short-term administration of ERT in postmenopausal women is associated with a modest increase in DAT in the putamen. These findings may further the understanding of bow ERT is associated with improvement in Parkinson's disease and late-onset schizophrenia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available